• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (4): 475-483.DOI: 10.3969/j.issn.1671-2587.2026.04.003

• 专家论坛 • 上一篇    下一篇

储存红细胞质量个性化智能评估装置的开发与应用——面向未来精准输血的新范式

张子健, 赵宁, 吕丽萍, 马平, 邓江, 张艳宇   

  1. 军事医学研究院,北京 100850
  • 收稿日期:2026-07-07 出版日期:2026-08-20 发布日期:2026-08-26
  • 通讯作者: 邓江,主要从事基于机器学习的精准输血医学研究,(E-mail)ammsdjxm@163.com。共同通信作者:张艳宇,主要从事血液质量监督与评价研究,(E-mail)swgczhyy@126.com。
  • 作者简介:张子健,主要从事血液质量检测与评价研究,(E-mail)zzj5105@163.com。

Intelligent Devices and Artificial Intelligence Applications for Individualized Assessment of Stored Red Blood Cell Quality: A New Paradigm in Precision Transfusion Medicine

ZHANG Zijian, ZHAO Ning, LV Liping, MA Ping, DENG Jiang, ZHANG Yanyu   

  1. Academy of Military Medical Sciences, Beijing 100850
  • Received:2026-07-07 Online:2026-08-20 Published:2026-08-26

摘要: 储存红细胞质量的个体化(个性化)精准评估是提升精准输血水平的关键需求,其理论依据在于红细胞在微观流变、代谢与形态学等层面的异质性会导致储存损伤的形成与演进呈现“非均一”特征。传统质控多依赖群体平均储存天数的宏观指标,在临床转化中面临敏感度不足、难以识别易损亚群以及需侵入性取样等困境。为突破上述瓶颈,本文系统梳理面向个体红细胞质量评估的智能化新装置与人工智能辅助系统的最新进展,重点包括微流控芯片平台,空间偏移拉曼光谱(spatially offset Raman spectroscopy, SORS)与光声成像等技术。与此同时,深度学习与机器学习能够对显微形态学特征进行自动表征与分类学习,进一步构建大数据驱动的质量评估体系。尽管当前仍存在临床放行标准不统一、纳米传感基底生物安全性评估不足以及成本收益不平衡等问题,未来仍有望在低成本无损床旁检测(point-of-care testing, POCT)与人工智能融合的基础上,建立决策链路,推动智能化、便捷化与临床可及的质量评估闭环形成,从而为突破当前储存损伤评估瓶颈提供理论基础与实践指引。

关键词: 红细胞储存损伤, 精准输血, 微流控芯片, 无损原位监测, 人工神经网络

Abstract: Individualized precision assessment of stored red blood cell (RBC) quality is a key requirement for advancing precision transfusion practices. The theoretical basis for this lies in the heterogeneity of red blood cells at the microscopic rheological, metabolic, and morphological levels, which leads to the formation and progression of storage lesions displaying "non-uniform" characteristics. Traditional quality control primarily relies on macro-indicators based on population-average storage duration, facing challenges in clinical translation including insufficient sensitivity, difficulty in identifying vulnerable subpopulations, and the need for invasive sampling. To overcome these limitations, this paper systematically reviews the latest developments in intelligent devices and artificial intelligence-assisted systems for individualized RBC quality assessment, with particular focus on microfluidic chip platforms, spatially offset Raman spectroscopy (SORS), and photoacoustic imaging technologies. Concurrently, deep learning and machine learning can perform automatic characterization and classification learning of microscopic morphological features, further establishing data-driven quality assessment frameworks. Although current challenges remain—including non-standardized clinical release criteria, insufficient biosafety assessment of nanosensing substrates, and cost-benefit imbalances—future prospects remain promising. By integrating low-cost, non-invasive point-of-care testing (POCT) with artificial intelligence, decision pathways can be established to promote the formation of intelligent, convenient, and clinically accessible quality assessment closed-loop systems. This approach will provide both theoretical foundation and practical guidance for overcoming the current bottleneck in storage lesion assessment.

Key words: Red blood cell storage lesion, Precision transfusion medicine, Microfluidic chips, Non-destructive in situ monitoring, Artificial neural networks

中图分类号: